Who has invested in Exai Bio?

Section 32, Casdin Capital, Two Sigma Ventures are named among the investors backing Exai Bio.

Exai Bio Funding: $68M Raised, Series A (2021)

Exai Bio funding overview

Exai Bio is based in San Francisco, CA. Exai Bio has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Exai Bio runs through 2021; nothing later has been disclosed. Investors on record include Section 32, Casdin Capital, Two Sigma Ventures. 3 distinct backers are named across the disclosed rounds.

Exai Bio at a glance

Total raised: $68M
Latest round: Series A
Latest round date: December 2021
Headquarters: San Francisco, CA
Notable investors: Section 32, Casdin Capital, Two Sigma Ventures

Frequently asked about Exai Bio funding

How much has Exai Bio raised?: Exai Bio has raised $68M in total disclosed funding across the rounds on record.
Who has invested in Exai Bio?: Section 32, Casdin Capital, Two Sigma Ventures are named among the investors backing Exai Bio.
What was the latest Exai Bio funding round?: The most recent disclosed round is a Series A, announced in December 2021.
Where is Exai Bio based?: Exai Bio is based in San Francisco, CA.
When did Exai Bio last raise?: The last disclosed Exai Bio round closed in December 2021 at Series A.

Round data for Exai Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco and backer lists below.

Exai Bio Funding: $68M Raised, Series A (2021)

Exai Bio funding overview

Exai Bio at a glance

Frequently asked about Exai Bio funding

Companies related to Exai Bio (36)

Browse related funding lists (7)